Glaucoma is a group of optic neuropathies that have a progressive degeneration of retinal ganglion cells and their axons, resulting in a characteristic appearance of the optic disc and visual field loss. Assessing functional loss in glaucoma has traditionally been done using standard automated perimetry (SAP). However, SAP requires considerable subjective input from the patient and is limited by large test-retest variability.
1 As SAP testing is generally performed in clinically based settings, limited resources frequently result in patients not undergoing the necessary number of tests over time, which may result in patients receiving a late diagnosis or a delayed detection of progression.